<DOC>
	<DOCNO>NCT00972634</DOCNO>
	<brief_summary>RATIONALE : A computer-based system assess symptom may effective patient metastatic advanced cancer . PURPOSE : This clinical trial study well computerized questionnaire work assess symptom , pain , depression , physical function patient metastatic and/or advance local/regional cancer .</brief_summary>
	<brief_title>Computerized Questionnaires Assessing Symptoms , Pain , Depression , Physical Function Patients With Metastatic and/or Advanced Locoregional Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility apply computer-based system symptom assessment classification palliative cancer care patient metastatic and/or advanced cancer . - Examine hypothesize difference across group relate acceptance computer ( i.e. , age , culture , stage disease , cognitive physical function , etc. ) . - Examine general user-friendliness tool . - Test validate performance select domain item classification assessment pain cachexia . - Explore validity domains item depression . OUTLINE : This multicenter study . All patient undergo computer-based assessment general symptom Edmonton Symptom Assessment System ( ESAS ) European Organization Research Treatment Cancer Core Quality Life ( EORTC QLQ C30 ) questionnaires assessment physical function , appetite/weight loss , depression Brief Patient Health Questionnaire 9 ( PRIME-MD PHQ9 ) . Patients score â‰¥ 1 ( 0-10 numerical rating score ) pain screen question without occurrence breakthrough pain ( BTP ) , undergo Alberta BTP Assessment tool assess precipitate factor pain , time pain relief intake medication , satisfaction medication . Patients complete question regard user-friendliness feasibility use computer end session .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis incurable cancer , include patient receive lifeprolonging treatment Metastatic and/or advance locoregional disease PATIENT CHARACTERISTICS : Able provide write informed consent Fluent language use study site PRIOR CONCURRENT THERAPY : No prior inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>depression</keyword>
	<keyword>cachexia</keyword>
	<keyword>pain</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>